EARLY ALZHEIMERS DISEASE
Clinical trials for EARLY ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria tested as potential Alzheimer's treatment
Disease control Recruiting nowThis study is testing whether a specific probiotic bacteria, called L. lactis CKDB001, can help slow down memory and thinking problems in people with early Alzheimer's disease. Over 24 weeks, 60 participants will take either the probiotic or a placebo pill to see if it improves t…
Matched conditions: EARLY ALZHEIMERS DISEASE
Phase: NA • Sponsor: CKD Bio Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major Alzheimer's trial tests drug to slow memory loss
Disease control Recruiting nowThis large Phase 3 trial is testing whether a daily pill called buntanetap can help people with early Alzheimer's disease. Researchers will enroll 760 adults aged 55-85 and randomly assign them to take either the real drug or a placebo for 18 months. The study will measure whethe…
Matched conditions: EARLY ALZHEIMERS DISEASE
Phase: PHASE3 • Sponsor: Annovis Bio Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC